USING SINGLE-CELL TRANSCRIPTOMICS TO UNDERSTAND TUMOR AND IMMUNE HETEROGENEITY DRIVING RESISTANCE TO IMMUNE THERAPY IN ADVANCED RCC

Dana-Farber Cancer Institute, Inc.

Investigators